FindTrial
Sign In

expression of VEGF, IL-6 and IL-8 in peritoneal fluid of ectopic decidua patient during pregnancy and its clinical significance

expression of VEGF, IL-6 and IL-8 in peritoneal fluid of ectopic decidua patient during pregnancy and its clinical significance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129533
Enrollment
Unknown
Registered
2026-08-06
Start date
2024-11-15
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ectopic decidua

Interventions

Control group:None
Observation group:None

Sponsors

Hefei Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Patients in the observation group met the indications for cesarean section and underwent cesarean section; 2.Ectopic decidua was found during cesarean section, and the diagnosis of ectopic decidua was confirmed by pathology; 3.Patients were informed about the content of this study, voluntarily participated and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who have received hormone therapy in the past 3 months; 2. Endocrine diseases; 3. Immune diseases; 4. Metabolic diseases; 5. Adenomyosis; 6. Uterine myoma patients; 7. Reproductive tract tuberculosis patients; 8. Ovarian cancer patients; 9. Other serious mental diseases.

Design outcomes

Primary

MeasureTime frame
VEGF content in peritoneal fluid;IL-8 content in peritoneal fluid;IL-6 content in peritoneal fluid;—

Secondary

MeasureTime frame
ultrasound findings;—

Countries

China

Contacts

Public ContactYin Wang

Hefei Maternal and Child Health Hospital

393153144@qq.com+86 551 6216 0038

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026